Molecular Determinants for the Action of Psychostimulants
精神兴奋剂作用的分子决定因素
基本信息
- 批准号:7319355
- 负责人:
- 金额:$ 12.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-15 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcuteAddressAdrenergic ReceptorAffectAffinity LabelsAgonistAmino AcidsAmphetaminesAntibodiesAntidepressive AgentsAntipsychotic AgentsArchaeal GenomeAreaAromatic Amino AcidsAspartateAtomic Force MicroscopyAwardBasic ScienceBehaviorBehavioralBenztropineBindingBinding SitesBiochemicalBiogenic Amine ReceptorsBiological AssayBiological ModelsCatecholaminesCellsChargeCholineChromatographyChronicClassCleaved cellCocaineCognitiveCollaborationsComplexConditionConsensusConsensus SequenceControlled StudyCryoelectron MicroscopyCrystallizationCrystallographyCultured CellsCyclophosphamide/Fluorouracil/PrednisoneCysteineD AspartateDNA Sequence RearrangementDRD2 geneDataDetergentsDevelopmentDimerizationDistalDisulfidesDivingDopamineDopamine AgonistsDopamine D2 ReceptorDopamine ReceptorDoseDrug abuseElectron Spin Resonance SpectroscopyEmotionalEndopeptidasesEngineeringEnvironmentEpitopesEscherichia coliExhibitsFaceFamilyFluorescence Resonance Energy TransferFluorescence SpectroscopyFusobacterium nucleatumG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesGerm CellsGoalsGrantGrowthHeterodimerizationHigher Order Chromatin StructureHomoHomologous GeneHomology ModelingHybridsIL3 geneIn VitroIndiumIndividualIntegral Membrane ProteinInterleukin-1Intracellular TransportIonsJournalsK-Series Research Career ProgramsKnock-in MouseLabelLaboratoriesLaboratory StudyLactococcus lactisLengthLeucineLigand BindingLigandsLinkLocationManuscriptsMapsMass Spectrum AnalysisMeasurementMeasuresMediatingMembraneMembrane ProteinsMetalsMethodologyMethodsModelingMolecularMolecular ConformationMolecular ProbesMolecular Sieve ChromatographyMolecular StructureMolecular TargetMorphologic artifactsMovementMusMutationN(delta)-acetylornithine, -isomerN-dodecanoylglutamic acid, -isomer, sodium saltN-terminalNatureNeuronsNeurotransmittersNorepinephrineNotificationNumbersOpioid ReceptorOrganismOrphanPathway interactionsPatternPeptide HydrolasesPharmaceutical PreparationsPhospho-Specific AntibodiesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPlayPliabilityPositioning AttributePredispositionPreparationPrincipal InvestigatorProcessPropertyProtein BindingProtein OverexpressionProteinsProteomicsProtomerPublicationsPublishingQuinpiroleReceptor ActivationRecombinantsRegulationResearchResistanceResolutionRewardsRhodopsinRoleSSTR5 geneScreening procedureSenior Scientist AwardSerineSideSignal TransductionSimulateSiteSodiumSomatostatinSpecificitySquidStable Isotope LabelingStagingStructureStructure-Activity RelationshipSulfhydryl ReagentsSulpirideSurfaceSynapsesSynaptic CleftSystemTestingTimeTissuesTracerTransgenic MiceTropanesTryptophanTyrosineUniversitiesVesicleWorkWritingYeastsaddictionaffinity labelingalpha-difluoromethyl-DOPA, -isomeralpha-methylornithine dihydrochloride, -isomeranalogbasecalmodulin-dependent protein kinase IIcombinatorialcrosslinkdesigndimerdopamine D4 receptordopamine transporterdopaminergic neurondrug of abuseexperienceextracellularflyhuman DRD4 proteinin vivoinhibitor/antagonistinsightmembermonomermultidisciplinarymutantnervous system disordernovelnovel strategiespreventprogramsprotein activationproteoliposomespsychostimulantreceptorreceptor functionreconstitutionresearch studyresponsereuptakeserotonin transportersingle moleculesmall moleculesmall molecule librariessodium ionsomatostatin receptor 5syntaxin 1synthetic peptidetime usetransmission processtryptophan analoguptakewater channel
项目摘要
DESCRIPTION (provided by applicant): The catecholamine dopamine (DA) plays a key role in the regulation of cognitive, emotional, and behavioral functions, and abnormalities in its regulation have been implicated in several psychiatric and neurological disorders. DA exerts it actions at D2-like and D1-like receptors, members of the G protein-coupled receptor (GPCR) family. DA reuptake by the DA transporter (DAT) is a principal mechanism for terminating dopaminergic transmission, and this protein is the primary molecular target of amphetamine, cocaine, and other psychostimulants. The Javitch laboratory studies structure-function relations and mechanisms of regulation of neurotransmitter transporters and related bacterial transporters, as well as mechanisms of dopamine receptor oligomerization and function. His long-term research goals are to: 1) Understand the structural bases of agonist and antagonist binding and specificity in G protein-coupled receptors, with a current focus on dopamine and opioid receptors. 2) Determine how agonist binding is transduced into G-protein activation. 3) Determine the structural bases of substrate translocation and inhibitor binding to the dopamine transporter. 4) Determine the mechanistic bases of amphetamine-induced dopamine efflux and the role of regulation of these processes in sensitization. The K Award enables the candidate to devote focused efforts to the exploration of new approaches, novel systems and various multidisciplinary methods and collaborations aimed at one of the central goals of the research program in the laboratory - the mechanisms of drugs of abuse. In collaboration with leading experts, individuals in the candidate's laboratory are now pursuing membrane protein crystallography and electron paramagnetic resonance & single molecule fluorescence spectroscopy of bacterial homologs of neurotransmitter transporter and are also pursuing work in knock-in mice and transgenic flies as model systems to probe molecular and mechanistic insights in a physiological background. These new approaches are being developed and used to lay the groundwork to maintain the candidate's research at the leading edge of the field of molecular mechanisms of drug abuse and actions of antipsychotic drugs. The support of the K05 Award would play an essential role in the candidate's continued growth by giving him the flexibility to focus in part outside of the area of his current methodologies and to fuse his own professional growth with that of his research program and his trainees.
描述(由申请人提供):儿茶酚胺多巴胺(DA)在认知、情绪和行为功能的调节中发挥着关键作用,其调节异常与多种精神和神经疾病有关。 DA 对 D2 样和 D1 样受体(G 蛋白偶联受体 (GPCR) 家族的成员)发挥作用。 DA 转运蛋白 (DAT) 的 DA 重摄取是终止多巴胺能传递的主要机制,该蛋白是安非他明、可卡因和其他精神兴奋剂的主要分子靶点。 Javitch实验室研究神经递质转运蛋白和相关细菌转运蛋白的结构-功能关系和调节机制,以及多巴胺受体寡聚化和功能的机制。他的长期研究目标是:1) 了解激动剂和拮抗剂结合的结构基础以及 G 蛋白偶联受体的特异性,目前的重点是多巴胺和阿片受体。 2) 确定激动剂结合如何转导为 G 蛋白激活。 3) 确定底物易位和抑制剂与多巴胺转运蛋白结合的结构基础。 4) 确定安非他明诱导的多巴胺流出的机制基础以及这些过程在致敏中的调节作用。 K 奖使候选人能够集中精力探索新方法、新颖系统以及各种多学科方法和合作,以实现实验室研究项目的中心目标之一——药物滥用机制。候选人实验室的人员与顶尖专家合作,目前正在研究神经递质转运蛋白细菌同系物的膜蛋白晶体学、电子顺磁共振和单分子荧光光谱学,并且还在以基因敲入小鼠和转基因果蝇为模型系统进行探索。生理背景下的分子和机制见解。这些新方法的开发和使用是为了奠定基础,以保持候选人的研究在药物滥用分子机制和抗精神病药物作用领域的领先地位。 K05 奖的支持将为候选人的持续成长发挥重要作用,让他能够灵活地专注于当前方法论领域之外的部分,并将自己的专业成长与他的研究项目和学员的专业成长融合起来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan A Javitch其他文献
Jonathan A Javitch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan A Javitch', 18)}}的其他基金
Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology
代谢型谷氨酸受体异聚化对信号传导和药理学的影响
- 批准号:
10637938 - 财政年份:2023
- 资助金额:
$ 12.31万 - 项目类别:
Functional validation of a role for the candidate gene Ctr9 in psychostimulant action
候选基因 Ctr9 在精神兴奋作用中的作用的功能验证
- 批准号:
10392183 - 财政年份:2022
- 资助金额:
$ 12.31万 - 项目类别:
Development of dopamine D2 receptor-targeted DARTs
多巴胺 D2 受体靶向 DART 的开发
- 批准号:
10376835 - 财政年份:2021
- 资助金额:
$ 12.31万 - 项目类别:
Probing mechanisms of amphetamine action at plasma membrane and vesicular transporters in vitro and in vivo
体外和体内苯丙胺对质膜和囊泡转运蛋白作用的探讨机制
- 批准号:
9311046 - 财政年份:2017
- 资助金额:
$ 12.31万 - 项目类别:
Probing mechanisms of amphetamine action at plasma membrane and vesicular transporters in vitro and in vivo
体外和体内苯丙胺对质膜和囊泡转运蛋白作用的探讨机制
- 批准号:
9449417 - 财政年份:2017
- 资助金额:
$ 12.31万 - 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
- 批准号:
10160626 - 财政年份:2016
- 资助金额:
$ 12.31万 - 项目类别:
Modulation of dopaminergic neurotransmission by ADGRL3, an adhesion GPCR associated with ADHD susceptibility
ADGRL3(一种与 ADHD 易感性相关的粘附 GPCR)对多巴胺能神经传递的调节
- 批准号:
9350414 - 财政年份:2016
- 资助金额:
$ 12.31万 - 项目类别:
Modulation of dopaminergic neurotransmission by ADGRL3, an adhesion GPCR associated with ADHD susceptibility
ADGRL3(一种与 ADHD 易感性相关的粘附 GPCR)对多巴胺能神经传递的调节
- 批准号:
9227923 - 财政年份:2016
- 资助金额:
$ 12.31万 - 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
- 批准号:
9920689 - 财政年份:2016
- 资助金额:
$ 12.31万 - 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
- 批准号:
9920454 - 财政年份:2016
- 资助金额:
$ 12.31万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
$ 12.31万 - 项目类别:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
MassHEAL%20-%20减少%20过量%20死亡%20by%2040%%20(2019-2023)
- 批准号:
10891912 - 财政年份:2023
- 资助金额:
$ 12.31万 - 项目类别:
Undernutrition, microbiota maturation, and adaptive immunity in Bangladeshi children
孟加拉国儿童的营养不良、微生物群成熟和适应性免疫
- 批准号:
10718949 - 财政年份:2023
- 资助金额:
$ 12.31万 - 项目类别:
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
- 批准号:
10569397 - 财政年份:2023
- 资助金额:
$ 12.31万 - 项目类别:
Contact Pathway Inhibitor to Prevent Vascular Access Failure
接触途径抑制剂以防止血管通路失败
- 批准号:
10604057 - 财政年份:2023
- 资助金额:
$ 12.31万 - 项目类别: